English
Аллергический ринит и обструктивное апноэ сна
DOI: https://dx.doi.org/10.18565/therapy.2024.2.100-108
Л.З. Болиева, А.Г. Малявин, М.Д. Даурова
1) ФГБОУ ВО «Северо-Осетинская государственная медицинская академия» Минздрава России, г. Владикавказ; 2) ФГБОУ ВО «Российский университет медицины» Минздрава России, г. Москва
Литература
1. Клинические рекомендации. Аллергический ринит. Российская ассоциация аллергологов и клинических иммунологов, Национальная медицинская ассоциация оториноларингологов, Союз педиатров России. Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 261. Доступ: http://cr.rosminzdrav.ru/schema/261_1 (дата обращения – 01.03.2022). (Clinical guidelines. Allergic rhinitis. Russian Association of Allergists and Clinical Immunologists, National Medical Association of Otorhinolaryngologists, Russian Union of Pediatricians. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 261. URL: http://cr.rosminzdrav.ru/schema/261_1 (date of access – 01.03.2022) (In Russ.)). 2. Ильина Н.И., Курбачева О.М., Павлова К.С., Польнер С.А. Федеральные клинические рекомендации: аллергический ринит. Российский аллергологический журнал. 2018; 14(2): 43–53. (Ilina N.I., Kurbacheva O.M., Pavlova K.S., Polner S.A. Federal clinical recommendations. Allergic rhinitis. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy. 2018; 14(2): 43–53 (In Russ.)). EDN: YOCWHP. 3. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт. 1998; 250 с. (Gushchin I.S. Allergic inflammation and its pharmacological control. Moscow: Farmarus Print. 1998; 250 pp. (In Russ.)). ISBN: 5-901029-04-6. 4. Хаитов М.Р., Намазова-Баранова Л.С., Ильина Н.И. с соавт. ARIA 2019: алгоритмы оказания помощи при аллергическом рините в России. Российский аллергологический журнал. 2020; 17(1): 7–22. (Khaitov M.R., Namazova-Baranova L.S., Ilyina N.I. et al. 2019 ARIA: Care pathways for allergic rhinitis in Russia. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy. 2020; 17(1): 7–22 (In Russ.)). https://doi.org/10.36691/RAJ.2020.17.1.001. EDN: HHBTEI. 5. Brozek J.L., Bousquet J., Baena-Cagnani C.E. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2017 revision. J Allergy Clin Immunol. 2017; 140(4): 950–58. https://doi.org/10.1016/j.jaci.2017.03.050. PMID: 28602936. 6. Wise S.K., Lin S.Y., Toskala E. et al. International Consensus Statement on Allergy and Rhinology: Allergic rhinitis. Int Forum Allergy Rhinol. 2018; 8(2): 108–352. https://doi.org/10.1002/alr.22073. PMID: 29438602. PMCID: PMC7286723. 7. Бузунов Р.В. Ожирение и синдром обструктивного апноэ во сне: как разорвать порочный круг. Эффективная фармакотерапия. 2020; 16(2): 30–33. (Buzunov R.V. Obesity and obstructive sleep apnea syndrome: how to break the vicious circle. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2020; 16(2): 30–33 (In Russ.)). https://doi.org/10.33978/2307-3586-2020-16-2-30-33. EDN: JQJAZI. 8. Guilleminault C., Tilkian A., Dement W.C. The sleep apnea syndromes. Annu Rev Med. 1976; 27: 465–84. https://doi.org/10.1146/annurev.me.27.020176.002341. PMID: 180875. 9. Горбунова М.В., Бабак С.Л., Малявин А.Г. Сердечно-сосудистые и метаболические нарушения у пациентов с обструктивным апноэ сна. Архивъ внутренней медицины. 2018; 8(1): 12–21. (Gorbunova M.V., Babak S.L., Malyavin A.G. Cardiovascular and metabolic disorders in patients with obstructive sleep apnea. Arkhiv vnutrenney meditsiny = Archive of Internal Medicine. 2018; 8(1): 12–21 (In Russ.)). https://doi.org/10.20514/2226-6704-2018-8-1-12-21. EDN: YNHAAI. 10. Young T., Palta M., Dempsey J. et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17): 1230–35. https://doi.org/10.1056/NEJM199304293281704. PMID: 8464434. 11. Kuniyoshi F.H., Garcia-Touchard A., Gami A.S. et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008; 52(5): 343–46. https://doi.org/10.1016/j.jacc.2008.04.027. PMID: 18652941. PMCID: PMC2598735. 12. Arzt M., Young T., Finn L. et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005; 172(11): 1447–51. https://doi.org/10.1164/rccm.200505-702OC. PMID: 16141444. PMCID: PMC2718439. 13. Wang H., Parker J.D., Newton G.E. et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007; 49(15): 1625–31. https://doi.org/10.1016/j.jacc.2006.12.046. PMID: 17433953. 14. Punjabi N.M., Shahar E., Redline S. et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol. 2004; 160(6): 521–30. https://doi.org/10.1093/aje/kwh261. PMID: 15353412. 15. Cao Y., Wu S., Zhang L. Association of allergic rhinitis with obstructive sleep apnea: A meta-analysis. Medicine (Baltimore). 2018; 97(51): e13783. https://doi.org/10.1097/MD.0000000000013783. PMID: 30572534. PMCID: PMC6319794. 16. Pace A., Iannella G., Rossetti V. et al. Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis. Medicina (Kaunas). 2020; 56(9): 454–65. https://doi.org/10.3390/medicina56090454. PMID: 32911862. PMCID: PMC7559128. 17. Wongvilairat S., Assanasen P., Banhiran, W. et al. The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis. Asian Pac J Allergy Immunol. 2022; 40(3): 205–9. https://doi.org/10.12932/ap-141218-0458. PMID: 31677615. 18. Craig T.J., McCann J.L., Gurevich F., Davies M.J. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol. 2004; 114(5 Suppl): 139–45. https://doi.org/10.1016/j.jaci.2004.08.044. PMID: 15536445. 19. Tashiro M., Mochizuki H., Iwabuchi K. et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002; 72(4–5): 409–14. https://doi.org/10.1016/s0024-3205(02)02276-2. PMID: 12467881. 20. Meltzer E.O. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”. Ann Allergy Asthma Immunol. 2000; 84(2): 176–87. https://doi.org/10.1016/S1081-1206(10)62750-0. PMID: 10719774. 21. Mullington J.M., Hinze-Selch D., Pollmacher T. Mediators of inflammation and their interaction with sleep: Relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci. 2001; 933: 201–10. https://doi.org/10.1111/j.1749-6632.2001.tb05825.x. PMID: 12000021. 22. Krouse H.J., Davis J.E., Krouse J.H. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002; 126(6): 607–13. https://doi.org/10.1067/mhn.2002.125300. PMID: 12087326. 23. Lunn M., Craig T. Rhinitis and sleep. Sleep Med Rev. 2011; 15(5): 293–99. https://doi.org/10.1016/j.smrv.2010.12.001. PMID: 21316270. 24. Maniaci A., Iannella G., Cocuzza S. et al. Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients. J Clin Med. 2021; 10(2): 277–96. https://doi.org/10.3390/jcm10020277. PMID: 33451164. PMCID: PMC7828672. 25. Chirakalwasan N., Ruxrungtham K. The linkage of allergic rhinitis and obstructive sleep apnea. Asian Pac J Allergy Immunol. 2014; 32(4): 276–86. PMID: 25543037. 26. Kheirandish-Gozal L., Gozal D. Obstructive sleep apnea and inflammation: Proof of concept based on two illustrative cytokines. Int J Mol Sci. 2019; 20(3): 459–78. https://doi.org/10.3390/ijms20030459. PMID: 30678164. PMCID: PMC6387387. 27. Shiefa S., Ashalatha R., Anjali R. Increased oxidative stress and altered antioxidants status in patients with chronic allergic rhinitis. Adv Biosci Biotechnol. 2012; 03(07): 951–56. https://doi.org/10.4236/abb.2012.327117. 28. Zheng M., Wang X., Zhang L. Association between allergic and nonallergic rhinitis and obstructive sleep apnea. Curr Opin Allergy Clin Immunol. 2018; 18(1): 16–25. https://doi.org/10.1097/ACI.0000000000000414. PMID: 29135515. 29. Ni K., Zhao L., Wu J. et al. Th17/Treg balance in children with obstructive sleep apnea syndrome and the relationship with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2015; 79(9): 1448–54. https://doi.org/10.1016/j.ijporl.2015.06.026. PMID: 26166452. 30. Tan H.L., Gozal D., Wang Y. et al. Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea. Sleep. 2013; 36(6): 913–22. https://doi.org/10.5665/sleep.2724. PMID: 23729935. PMCID: PMC3648675. 31. Tan H.L., Gozal D., Samiei A. et al. T regulatory lymphocytes and endothelial function in pediatric obstructive sleep apnea. PLoS One. 2013; 8(7): e69710. https://doi.org/10.1371/journal.pone.0069710. PMID: 23936084. PMCID: PMC3728363. 32. Bindu B., Singh G.P., Chowdhury T., Schaller B. Rhinitis and sleep disorders: The trigeminocardiac reflex link? Med Hypotheses. 2017; 103: 96–99. https://doi.org/10.1016/j.mehy.2017.04.019. PMID: 28571821. 33. Young T., Finn L., Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol. 1997; 99(2): 757–62. https://doi.org/10.1016/s0091-6749(97)70124-6. PMID: 9042068. 34. Lofaso F., Coste A., d’Ortho M. et al. Nasal obstruction as a risk factor for sleep apnea syndrome. Eur Respir J. 2000; 16(4): 639–43. https://doi.org/10.1034/j.1399-3003.2000.16d12.x. PMID: 11106205. 35. Бузунов Р.В., Легейда И.В. Храп и синдром обструктивного апноэ сна. М. 2010: 82. (Buzunov R.V., Legeida I.V. Snoring and obstructive sleep apnea syndrome. Moscow. 2010: 82 pp. (In Russ.)). 36. Egan K.K., Kezirian E.J., Kim D.W. Nasal obstruction and sleep-disordered breathing. Operative Techniques in Otolaryngology – Head and Neck Surgery. 2006; 17(4): 268–72. https://doi.org/10.1016/j.otot.2006.10.004. 37. White D.P., Cadieux R.J., Lombard R.M. et al. The effects of nasal anesthesia on breathing during sleep. Am Rev Respir Dis. 1985; 132(5): 972–75. https://doi.org/10.1164/arrd.1985.132.5.972. PMID: 4062052. 38. Basner R.C., Simon P.M., Schwartzstein R.M. et al. Breathing route influences upper airway muscle activity in awake normal adults. J Appl Physiol (1985). 1989; 66(4): 1766–71. https://doi.org/10.1152/jappl.1989.66.4.1766. PMID: 2732169. 39. Fitzpatrick M.F., McLean H., Urton A.M. et al. Effect of nasal or oral breathing route on upper airway resistance during sleep. Eur Respir J. 2003; 22(5): 827–32. https://doi.org/10.1183/09031936.03.00047903. PMID: 14621092. 40. Koutsourelakis I., Vagiakis E., Roussos C. et al. Obstructive sleep apnoea and oral breathing in patients free of nasal obstruction. Eur Respir J. 2006; 28(6): 1222–28. https://doi.org/10.1183/09031936.00058406. PMID: 17005578. 41. Olsen K.D., Kern E.B., Westbrook P.R. Sleep and breathing disturbance secondary to nasal obstruction. Otolaryngol Head Neck Surg. 1981; 89(5): 804–10. https://doi.org/10.1177/019459988108900522. PMID: 6799913. 42. Zwillich C.W., Pickett C., Hanson F.N. et al. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis. 1981; 124(2): 158–60. https://doi.org/10.1164/arrd.1981.124.2.158. PMID: 7258828. 43. McNicholas W.T., Coffey M., Boyle T. Effects of nasal airflow on breathing during sleep in normal humans. Am Rev Respir Dis. 1993; 147(3): 620–23. https://doi.org/10.1164/ajrccm/147.3.620. PMID: 8442596. 44. Smith R.M., Gonzalez C. The relationship between nasal obstruction and craniofacial growth. Pediatr Clin North Am. 1989; 36(6): 1423–34. https://doi.org/10.1016/s0031-3955(16)36797-9. PMID: 2587086. 45. Ng D.K., Chan C.H., Hwang G.Y. et al. A review of the roles of allergic rhinitis in childhood obstructive sleep apnea syndrome. Allergy Asthma Proc. 2006; 27(3): 240–42. https://doi.org/10.2500/aap.2006.27.2855. PMID: 16913267. 46. Kalpaklioglu A.F., Kavut A.B., Ekici M. Allergic and nonallergic rhinitis: The threat for obstructive sleep apnea. Ann Allergy Asthma Immunol. 2009; 103(1): 20–25. https://doi.org/10.1016/S1081-1206(10)60138-X. PMID: 19663122. 47. Ruhle K.H., Nilius G. Mouth breathing in obstructive sleep apnea prior to and during Nasal continuous positive airway pressure. Respiration. 2008; 76(1): 40–45. https://doi.org/10.1159/000111806. PMID: 18042974. 48. Kiely J.L., Nolan P., McNicholas W.T. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004; 59(1): 50–55. PMID: 14694248. PMCID: PMC1758841. 49. Lavigne F., Petrof B.J., Johnson J.R. et al. Effect of topical corticosteroids on allergic airway inflammation and disease severity in obstructive sleep apnoea. Clin Exp Allergy. 2013; 43(10): 1124–33. https://doi.org/10.1111/cea.12158. PMID: 24074330. 50. Meltzer E.O., Munafo D.A., Chung W. et al. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol. 2010; 105(1): 65–74. https://doi.org/10.1016/j.anai.2010.04.020. PMID: 20642206. 51. Acar M., Cingi C., Sakallioglu O. et al. The effects of mometasone furoate and desloratadine in obstructive sleep apnea syndrome patients with allergic rhinitis. Am J Rhinol Allergy. 2013; 27(4): 113–16. https://doi.org/10.2500/ajra.2013.27.3921. PMID: 23883803. 52. Brouillette R.T., Manoukian J.J., Ducharme F.M. et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr. 2001; 138(6): 838–44. https://doi.org/10.1067/mpd.2001.114474. PMID: 11391326. 53. Esteitie R., Emani J., Sharma S. et al. Effect of fluticasone furoate on interleukin 6 secretion from adenoid tissues in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2011; 137(6): 576–82. https://doi.org/10.1001/archoto.2011.86. PMID: 21690510. 54. Mansfield L.E., Diaz G., Posey C.R., Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004; 92(2): 240–44. https://doi.org/10.1016/S1081-1206(10)61554-2. PMID: 14989393. 55. Nayak A., Langdon R.B. Montelukast in the treatment of allergic rhinitis: An evidence-based review. Drugs. 2007; 67(6): 887–901. https://doi.org/10.2165/00003495-200767060-00005. PMID: 17428106. 56. Razi С., Bakirtas А., Harmanci К. et al. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006; 97(6): 767–74. https://doi.org/10.1016/S1081-1206(10)60968-4. PMID: 17201236. 57. Goldbart A.D., Goldman J.L., Li R.C. et al. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest. 2004; 126(1): 13–18. https://doi.org/10.1378/chest.126.1.13. PMID: 15249436. 58. Bao J.-L., Xinyuan-Gao, Han Y.B. et al. Efficacy and safety of montelukast for pediatric obstructive sleep apnea syndrome: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(3): e23958. http://dx.doi.org/10.1097/MD.0000000000023958. PMID: 33545976. PMCID: PMC7837961. 59. Smith D.F., Sarber K.M., Spiceland C.P. et al. Effects of medical therapy on mild obstructive sleep apnea in adult patients. J Clin Sleep Med. 2019; 15(7): 979–83. https://doi.org/10.5664/jcsm.7876. PMID: 31383235. PMCID: PMC6622504. 60. Clarenbach C.F., Kohler M., Senn O. et al. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res. 2008; 17(4): 444–49. https://doi.org/10.1111/j.1365-2869.2008.00667.x. PMID: 18710420. 61. McLean H.A., Urton A.M., Driver H.S. et al. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea. Eur Respir J. 2005; 25(3): 521–27. https://doi.org/10.1183/09031936.05.00045004. PMID: 15738298.
Об авторах / Для корреспонденции
Лаура Зелимхановна Болиева, д. м. н., профессор, заведующая кафедрой фармакологии с клинической фармакологией ФГБОУ ВО «Северо-Осетинская государственная медицинская академия» Минздрава России. Адрес: 362019, г. Владикавказ, ул. Пушкинская, д. 40.
E-mail: bolievalz@mail.ru
ORCID: https://orcid.org/0000-0002-3763-8994
Андрей Георгиевич Малявин, д. м. н., профессор кафедры фтизиатрии и пульмонологии ФГБОУ ВО «Российский университет медицины» Минздрава России. Адрес: 107150, г. Москва, ул. Лосиноостровская, д. 39, стр. 2.
E-mail: maliavin@mail.ru
ORCID: https://orcid.org/0000-0002-6128-5914
Мадина Даурбековна Даурова, к. м. н., доцент кафедры фармакологии с клинической фармакологией ФГБОУ ВО «Северо-Осетинская государственная медицинская академия» Минздрава России. Адрес: 362019, г. Владикавказ, ул. Пушкинская, д. 40.
E-mail: daurovamadina@yandex.ru
Похожие статьи
